Abstract
INTRODUCTION
The mammalian intestine is responsible for the digestion and absorption of ingested food. However, the secretion and absorption of electrolytes and fluid are also essential functions of the intestine, in particular of intestinal epithelial cells. In humans, the gastrointestinal (GI) tract secretes 8-10 liters day −1 of fluid in the face of ingested food containing 1.5-2 liters day −1 of fluid. Most fluid is (re)absorbed by the small intestine (∼95%) and large intestine (∼4%) of the GI tract. The small intestine secretes ∼1 liter day −1 and (re)absorbs ∼6.5 liters day −1 , making it the major net fluid absorber. Because there is no active water movement in the human body, GI epithelial cells drive fluid movement through active movement of Na + and Cl − (discussed in this review) or HCO 3 − (beyond the scope of this review). In the intestine, there are four modes of Na + and Cl − movement: (a) nutrient-coupled Na + absorption, (b) electroneutral NaCl absorption, (c) electrogenic Cl − secretion by the cystic fibrosis transmembrane conductance regulator (CFTR), and (d ) electrogenic Na + absorption by the epithelial Na + channel (ENaC). The four modes mentioned here are described in detail in the following paragraphs.
Nutrient-Coupled Na
+ Absorption
In the 1960s, transepithelial sugar and amino acid movement was measured using the shortcircuit current technique (the Ussing chamber). These studies found that absorption is dependent on extracellular (luminal) Na + . This nutrient-coupled Na + absorption is now explained by the function of Na + /glucose-linked transporters (SGLTs, also known as Slc5 proteins), several Na + /amino acid cotransporters (Slc6, Slc38, etc.), and Na + -coupled solute carriers (see http://www.bioparadigms.org/ slc/menu.asp). The transepithelial Na + movement generates a lumen-negative (mucosanegative) transepithelial voltage facilitating paracellular Cl − and fluid absorption. This absorption can be regulated by enterotoxins and is thus also used as a route for therapeutically increasing Na + absorption via oral rehydration.
Electroneutral NaCl Absorption
During the 1960s to 1980s, short-circuitcurrent studies also demonstrated that the small intestinal and proximal colonic mucosa has basal NaCl and fluid absorption in the absence of nutrients and is not associated with transepithelial currents (Figure 1a) . These findings were in contrast to other modes of Na + and Cl − transport, all of which caused transepithelial currents. Therefore, this absorption mode is termed electroneutral NaCl absorption. These studies demonstrated that the coupled function of an apical Na + /H + exchanger(s) and a Cl − /HCO 3 − exchanger(s) mediates absorption, the details of which are highlighted in this review.
Electrogenic Cl − Secretion
When the intestinal mucosa (apical or luminal surface) is stimulated by agents that increase intracellular cyclic AMP (cAMP), Ca 2+ , or cyclic GMP (cGMP), electroneutral NaCl absorption is inhibited, and Cl − secretion is activated (1) (Figure 1b) . Apical Cl − channel CFTR mediates such secretion (2). The inside negative electric potential of epithelial cells provides the driving force to secrete Cl − . This movement generates a lumen-negative electrical difference that results in paracellular Na + secretion, and CFTR-mediated electrogenic Cl − secretion occurs in all regions of the small and large intestines.
Electrogenic Na + Absorption
Electrogenic Na + absorption (3, 4), a rheogenic mode, is specific to the distal colon. Here the transepithelial electrical resistance is higher than that of other GI segments. Colonic transepithelial voltage (V t ) exceeds −20 mV. In the colon, luminal Na + is much lower than in other segments and decreases in a proximalto-distal manner. This lumen-negative Molecules involved in electroneutral NaCl absorption. A Na + /H + exchanger (NHE3) and anion exchangers (Slc26a3/6/9) mediate apical absorption of NaCl. Na + /K + -ATPase (NKA) and ClC-2 chloride channel mediate basolateral movement of NaCl. Metabolic CO 2 is the source of H + and HCO 3 − ions via intracellular carbonic anhydrase II (CA) catalysis. Cystic fibrosis transmembrane conductance regulator (CFTR) mediates electrogenic Cl − secretion. (c) Direct or NHEregulatory factor (NHERF)-mediated interaction between CFTR and transporters. Known interactive activation (+) and inhibition (−) are shown; the question mark denotes that whether the interaction is activating or inhibiting is unknown. R, R-region of CFTR; S, STAS (sulfate transporter antisigma domain) of Slc26s. Slc9 is a family of Na + /H + exchangers that consists of eight membrane proteins (10, 11). NHE2 (12, 13) and NHE3 (14, 15) were first identified as NHE1 homologs, and their transcripts are highly expressed in the GI tract (stomach, small intestine, large intestine) and the kidney. In contrast to NHE1 at the basolateral membrane, NHE2 and NHE3 are found at the brush border (apical) membrane of the intestinal epithelium (jejunum, ileum, and colon) and at the renal tubule (proximal tubule and thick descending limb of Henle's loop). NHE2 and NHE3 activity has been studied by expressing the recombinant proteins in NHE-null cell lines (PS120 or SP-1 Slc26a9 is another anion transporter in the GI tract (53) with functional multiplicity (Figure 1 ): It is an nCl − /HCO 3 − exchanger, a Cl − channel, and a Na + /anion cotransporter (7). As for Slc26a3 and Slc26a6, Slc26a9 is also localized to the apical pole of epithelial cells (7, 47, 53, 54). Interaction with the R-region of CFTR and the Slc26-STAS domain stimulates the activity of Slc26a3/a6 (27) (Figure 1c) . Interestingly, this same STAS/R-region interaction leads to inhibition of Slc26a9 activity (Figure 1c ) (55). Slc26a9 −/− mice have poor stomach acid secretion and loss of tubulovesicles in parietal cells (9). Although Slc26a9 is present in the small intestine (53), Slc26a9 −/− mice do not have an obvious intestinal phenotype. This scenario makes sense, as Slc26a9 in the intestine is secondary to CFTR Cl − channels as well as Slc26a3/a6. Nonetheless, because Slc26a9 has opposite interaction regulation, Slc26a9 activity may be unchecked in the absence or misdirection of CFTR. This of course would affect the severity of intestinal cystic fibrosis phenotypes.
NHE: Na

Basolateral Transport
Although apical transporters and channels in the intestine have been the subject of intense recent study, the basolateral (serosal, or blood-side) transporters and channels are equally important. That said, details of basolateral transport in NaCl absorption are limited. Figure 1a illustrates that once Na + and Cl − are apically absorbed, a functional combination of a Cl − channel (ClC-2) (56-59), NKA, and a K + channel (Kir 7.1) (60, 61) are the major players in the basolateral step. Moreover, ClC-2 is necessary (in the jejunum) to recover paracellular permeability (barrier function) after ischemia (62) and is associated at lateral membranes with villus and tight junction function (63). Clinically, lubiprostone (SPI-0211, a Cl − channel activator) is used to treat (reverse) constipation (64). Lubiprostone activates intestinal ClC-2 channels (65) but in some circumstances also requires CFTR function (66). The role of CFTR, however, is controversial (67). ClC-2 can be turned down by α 1 -adrenergic nerves (68). The K + channel (presumably Kir 7.1) is needed to recycle K + after the NKA exchanges 2K + for 3Na + to complete the NaCl blood-exit step (Figure 1a) .
REGULATION OF ION TRANSPORTERS IN EPITHELIAL CELLS
In the epithelial cells of the small intestine and proximal colon, intracellular second messengers-cAMP, Ca 2+ , and cGMPregulate electroneutral NaCl absorption. All (76) (77) (78) , or cGMP (71), electroneutral NaCl absorption is inhibited, and electrogenic Cl − secretion is activated. NHE3 is one of the main targets of these second messengers. These inhibitory mechanisms have been analyzed mainly in exogenous expression systems (mammalian culture) (for reviews, see References 10, 79, and 80) and knockout mice (81, 82) . This inhibition requires both second messenger-activated protein kinases and the NHE-regulatory factor (NHERF) scaffold proteins. Cultured cells and mice lacking NHERF(s) do not show second messengermediated inhibition of NHE3. NHERF(s) mediates interaction among the C-terminal PDZ-binding motif of NHE3, other membrane proteins, cytoskeleton, protein kinases, etc. cAMP-mediated inhibition of NHE3 requires NHERF1 (NHERF), NHERF2 (E3KARP) (83) , and NHERF3 (PDZK1) (81) . Similarly, Ca 2+ -mediated inhibition of NHE3 requires NHERF2 (84, 85) and NHERF3 (81), but not NHERF1. NHE3 inhibition by cGMP requires NHERF2, but not NHERF1 or NHERF3 (81, 86) . cAMP activates protein kinase A (PKA)II, which anchors to NHERF1/2 via the cytoskeletal protein ezrin (also known as cytovillin or villin2), directly phosphorylating multiple serine residues in the cytoplasmic domain of NHE3 (83, 87) . Ca 2+ induces membrane localization of protein kinase C (PKC)α, which interacts with NHERF2 and α-actinin 4 (84, 85, 88) and phosphorylates NHE3 (89) . cGMP activates cGMP-dependent protein kinase II (cGKII or PKGII), which interacts with NHERF2, yet it is not known if cGKII directly phosphorylates NHE3. In the renal proximal tubule (90) and in cultured Caco-2 cells (91) , NHE3 is present in both apical membrane and clathrinassociated subapical endosomes, the latter of which constitute the major endocytic pathway. cAMP (92) and Ca 2+ (91) stimulate NHE3 internalization in Caco-2 cells; this endocytic pathway requires synaptotagmin 1 and adaptor protein 2 (AP2) (92) . In vitro, NHE3 phosphorylated by PKAα is still active (93) . Thus, phosphorylation-mediated internalization of NHE3 seems to be the dominant mechanism for NHE3 inhibition by second messengers.
Conversely, activation of NHE3 occurs by decreased intracellular pH (pH i ) or increased cellular metabolism (e.g., glucose transport and decreased pH i ) (94) . Ezrin controls this NHE3 activation by brush border translocation (95) .
Regulation of NHE3 and Na
+ /K + -ATPase by Glucocorticoid, SGK1, and PI3K
In small intestine epithelial cells, glucocorticoids activate electroneutral Na + absorption (75), NKA (75) , and SGLT1 (72, 96). The promoter of the rat Nhe3 gene has binding sites for glucocorticoid receptor (GR) and is activated by glucocorticoids (97) . NHE3 is also activated by glucocorticoids via SGK1 phosphorylation (73). Glucocorticoids activate SGK1 by inducing SGK1 gene expression (∼20 min); this activation occurs through stimulation of PI3-kinase (PI3K) (6, 98, 99 activates 3-phosphoinositide-dependent protein kinase-1 (PDK1), which directly phosphorylates SGK1 to activate it. NHE3 activation by SGK1 depends on the combined interaction of NHE3 and SGK1 with NHERF2 and then phosphorylation at S663 of NHE3 by SGK1 (73, 100). Analyses of Sgk1 −/− mice demonstrated that glucocorticoids enhance intestinal NHE3 and SGLT1 protein abundance at the brush border of wild-type mice but not that of Sgk1 −/− mice (72). In the proximal colon, mineralocorticoids also activate NHE3 (6, 74). There is a differential effect of mineralocorticoids in small versus large intestine on NHE3 activation. This difference arises from the differential expression and activity of 11β-hydroxysteroid dehydrogenase (11β-HSD2), which is required for mineralocorticoid function mediated by mineralocorticoid receptors (101) . (102) . In contrast to NHE3 regulation, the inhibitory mechanism of Slc26a3 and Slc26a6 is poorly understood.
Regulation of Slc26a3/a6 by Second Messengers
SLC26A3 has a C-terminal PDZ-binding motif, which can interact with the PDZ-2 domain of NHERF2 (103) has no transport activity after removal of its Cterminal PDZ-binding motif (107, 108) .
In contrast to the scenario with Slc26a3, PKC does regulate Slc26a6 activity (109) . In HEK293 cells or in Xenopus oocytes, PKC seems to dissociate intracellular carbonic anhydrase II (CAII) from its binding site on Slc26a6 (109, 110) . CAII catalyzes the reversible conversion between CO 2 and HCO 3 − ; this process supplies the HCO 3 − substrate to Slc26a6. Slc26a6 has a binding site for CAII, the deletion of which decreases Cl − /HCO 3 − exchange activity (110) . Mechanistically, PKC activation reduces the Slc26a6/CAII association, resulting in reduced Slc26a6 activity in HEK293 cells (110) . In Xenopus oocytes, PKCδ mediates PMA-induced Slc26a6 inhibition and internalization (109) . CAII is also required for full Slc26a3 activity in HEK293 cells, but direct interaction with CAII does not stimulate Slc26a3 transport activity (111) .
Cross-Regulation of NHE3, SLC26s, and CFTR
In the small intestine, absorption of NaCl and nutrients is mediated mainly by villus cells, whereas secretion of fluid containing Cl − and HCO 3 − is mediated mainly by crypt cells. These findings are the synthesis of immunohistochemical analyses demonstrating variable distribution of ion and nutrition transporters and channels (51, 112). At the same time, it is also believed that electroneutral NaCl absorption and electrogenic Cl − secretion occur in the same cells where transporters form macromolecular complexes, which presumably allows the transporters to regulate and be regulated by each other. How can this occur?
At the brush border, NHERFs scaffold transporters/channels (NHEs, Slc26s, and CFTR), cytoskeletal molecules, and kinases, as (27, 102) . This model is developed for the fluid secretion of pancreatic duct cells, but a similar system may be present in the intestinal epithelium. Conversely, when Slc26a9-STAS and R-CFTR interact, Slc26a9 function is inhibited, and this interaction-mediated inhibition does not require phosphorylation (55).
Studies using jejunal mucosa of CFTR −/− mice indicated that such mice lack not only cAMP-mediated Cl − secretory activity but also cAMP-mediated inhibition of electroneutral NaCl absorption (113) . These data suggest in vivo involvement of CFTR in the regulation of NHEs and Slc26s (4, 114). CFTR activation reduces the cell volume in the villus epithelium and induces cell shrinkage. Hypertonic medium (causing cell shrinkage) also inhibits electroneutral NaCl absorption (115) . In contrast, inhibition of duodenal NHEs by certain inhibitors can stimulate CFTR and HCO 3 − secretion (112, 116) . Cultured cells coexpressing NHE3, CFTR, and NHERF2 show inhibition of PKA-mediated CFTR activity, which depends on the interaction of NHE3 and NHERF2 (117) .
Coexpression of Slc26a3 and NHE (NHE2 or NHE3) results in transport activation (106) . In this system, anion inhibitors (e.g., DIDS and niflumic acid) block not only Slc26a3 activity but also NHE activity. Likewise, dimethylamiloride (an NHE inhibitor) blocks NHE2/3 activity as well as Slc26a3 activity.
Increased cellular cAMP is restored to basal levels by (a) hydrolysis of cAMP to 5 -AMP by phosphodiesterases (PDEs) or (b) cAMP efflux by MRP4 (ABCC4, an ABC transporter). MRP4 physically associates with CFTR via NHERF3 and thereby inhibits CFTR (118) .
MRP4 may also control NHE3 activity by regulating local intracellular [cAMP] .
REGULATION OF EPITHELIAL NaCl ABSORPTION
Epithelial absorption and secretion in the small intestine are regulated by the endocrine system, the autonomic nerve system, and the immune system (Figure 2) . The intestine has many enteric nerves that form interconnected networks within the intestinal wall and project directly to the epithelium. Thus, both direct regulation and enteric nerve-mediated regulation of epithelial cell transport are operative.
Enteric nerves are composed of the myenteric plexus and the submucosal plexus, which can function even when disconnected from the central nerve system (119) . Both enteric nerves and epithelial cells are regulated by sympathetic nerves (proabsorptive effect), parasympathetic nerves (secretory/antiabsorptive effect), the endocrine system and paracrine system (pro-and antiabsorptive effect), and immune system (secretory effect) (120) (121) (122) (123) . Although the mechanisms of enteric nerve-mediated regulation are not fully understood, the end result is mediated predominantly by norepinephrine (proabsorptive effect), somatostatin (proabsorptive effect), acetylcholine (secretory effect), and vasoactive intestinal peptide (VIP) (secretory effect). Regulation of NHE3 by the endocrine system, the nervous system, and the immune system. Absorptive (antisecretory; red ) and secretory (antiabsorptive; blue) signals are indicated. Abbreviations: 5-HT, 5-OH-tryptamine or serotonin; AII, angiotensin II; ACh, acetylcholine or cholinergic neuron; ANP, atrial natriuretic peptide; cGKII, cGMP-dependent protein kinase II; EC, enterochromaffin cell; EK, enkephalin; GC, glucocorticoid; GN, guanylin; IFN-γ, interferon-γ; NE, norepinephrine or norepinephrinergic neuron; NHE3, Na + /K + exchanger 3; NPY, neuropeptide Y; PGE 2 , prostaglandin E 2 ; PKAα, cAMP-dependent protein kinase α; PKCα, protein kinase Cα; PYY, peptide YY; SGK1, serum-and glucocorticoid-regulated protein kinase 1; SP, substance P; SST, somatostatin; Th1, T helper cell type 1; VIP, vasoactive intestinal peptide or VIPergic neuron; UGN, uroguanylin.
Secretory Regulation by
5-HT:
5-OH-tryptamine; also known as serotonin Substance P is an 11-amino-acid peptide, and its receptor is neurokinin 1 receptor (NK1). Substance P is found in myenteric and submucosal neurons and has a secretory effect (125) . A voltage-gated Na + channel blocker, tetrodotoxin, largely inhibits this secretory effect, suggesting that secretomotor neurons mediate the effect. Both cholinergic and noncholinergic secretomotor neurons are involved; NK1 mediates the cholinergic effect (125, 126) .
Serotonin [also known as 5-OH-tryptamine (5-HT)] is secreted from both the enteric nerves in the myenteric plexus and enterochromaffin (EC) cells (127, 128) , which sense luminal molecules (129) . The antiabsorptive and prosecretory effect of 5-HT is mediated predominantly by cholinergic and VIP secretomotor neurons. In Caco-2 cells, the 5-HT 4 receptor mediates PKCα activation, inhibition of NHE activity, and reduction of NHE3 transcription (130) . 5-HT also modifies the brush border architecture, which in turn reduces NHE3 function (131) . Norepinephrine (secreted by the adrenal gland or sympathetic nerve termini) and other catecholamines increase electroneutral NaCl absorption and decrease electrogenic Cl − secretion by intestinal mucosa. Catecholamines act at the α 2 -adrenergic receptor (132) on epithelial cells (133) . The α 2 -adrenergic receptor couples with inhibitory G proteins G i2 and G i3 (134) , which antagonize cAMP production. Additionally, second messenger-independent inhibition of Cl − secretion by G i has been suggested for colonic epithelium (135) . Catecholamines (through the α 2 -adrenergic receptor) also elicit noradrenergic inhibitory postsynaptic potentials (IPSPs) of VIP secretomotor neurons in the submucosal plexus (120, 136) .
Somatostatin is a 14-or 28-amino-acid peptide secreted by extrinsic and intrinsic neurons of the intestinal myenteric and submucosal plexus, as well as by endocrine D cells in the epithelium throughout the gut (137, 138) . Somatostatin analogs activate electroneutral NaCl absorption in the intestine. Secretory diarrhea caused by VIP-producing (Verner-Morrison syndrome) or serotonin-producing (carcinoid syndrome) tumors demonstrates an inhibitory effect of somatostatin (139) . Somatostatin receptors (SSTR1 and SSTR3) are expressed in the epithelium as well as in enteric neurons of the submucosal and myenteric plexuses (140) . SSTR2 is expressed in enteric neurons but not in epithelial cells (141) . Somatostatin (via SSTR1/SSTR2) also elicits nonadrenergic IPSPs of VIP secretomotor neurons (120, 136) .
Opioids (morphine, enkephalin) cause small intestine absorption (142, 143) . The δ-opioid receptor is found in submucosal and myenteric neurons and mediates the inhibition of VIP secretomotor neurons by enkephalin. Prolonged morphine use results in astriction by stimulating NaCl absorption. Accordingly, enkephalinase is a drug target for diarrhea.
Neuropeptide Y is a 36-amino-acid peptide and is present in both myenteric and submucosal neurons (144, 145) . In the submucosal plexus, neuropeptide Y is found in cholinergic and noncholinergic secretomotor neurons. Neuropeptide Y inhibits VIP-induced cAMP synthesis and Cl − secretion, as well as prostaglandin-elicited Cl − secretion. The absorptive (antisecretory) effect of neuropeptide Y is mediated by norepinephrine (α 2 -adrenergic receptors) in the ileum (146) , whereas neuropeptide Y-elicited absorption is mediated via Y 1 receptors in the human colonic epithelium (144) .
Regulation by the Paracrine System and the Endocrine System
Guanylin and uroguanylin are 15-16-aminoacid peptides and are present in serotoninpositive EC cells of the small intestine (147) . Luminal peptide secretion, stimulated by salt ingestion, elicits an increase in intracellular cGMP in epithelial cells via the apical receptor for guanylate cyclase C (GC-C) (148, 149) .
Peptide YY (PYY) is a 36-amino-acid gut hormone that is released from endocrine L cells of the ileal mucosa following a meal. PYY shares sequence homologies and therefore also a receptor with NPY. Like NPY, PYY is absorptive (antisecretory) in the small intestine (145).
As mentioned above, glucocorticoids activate electroneutral NaCl absorption as well as nutrient-coupled Na + absorption in the small intestine. Mineralocorticoids play a significant role in the stimulation of colonic Na + absorption but have little effect on the regulation of small intestinal NaCl absorption. Low doses of angiotensin II (which acts at the AT 2 receptor) stimulate intestinal electroneutral NaCl absorption (150) indirectly via norepinephrine secretion by sympathetic nerves (151, 152 ). Angiotensin II also antagonizes the secretory effect of VIP (153) .
Atrial natriuretic peptide (ANP) and its related peptides [B-type natriuretic peptide (BNP) and C-type natriuretic peptide (CNP)] are a family of peptides that reduce blood pressure and induce natriuresis. Natriuretic peptides reduce intestinal NaCl and water absorption and increase intestinal fluid content (154) (155) (156) (157) . This natriuretic action affects the jejunum but not the ileum in dog (155) . ANP stimulates cGMP synthesis in cultured rat ileal cells via the guanylate cyclase A receptor (157, 158) . The antiabsorptive effect of natriuretic peptide is inhibited by tetrodotoxin and an antagonist of 5-HT receptor, suggesting the mediation of enteric nerves (159) . However, the intestinal role of natriuretic peptides is still controversial, and detailed regulatory mechanisms have not been completely clarified.
Immune Regulation of Secretion
Mediators of enteric immune system also have secretory (antiabsorptive) effects on intestinal epithelium (160) . Prostaglandin E 2 (PGE 2 ) increases electrogenic Cl − secretion and inhibits electroneutral NaCl absorption (161) . Because atropine or tetrodotoxin does not inhibit these effects (162), PGE 2 may directly induce intracellular cAMP to be activated by its receptors present in the plasma membrane of intestinal epithelium (163) . PGE 2 is secreted by activated fibroblasts (164) , and indomethacin inhibits such secretion (162) .
Histamine, secreted by activated mast cells, elicits a short-circuit current in intestinal epithelium. Atropine or tetrodotoxin blocks this current in rat jejunum (162) , suggesting the mediation of cholinergic enteric nerves. In the colon, the histamine H 1 receptor (which increases intracellular [Ca 2+ ]) directly mediates secretion by the epithelial cells (165) . Activated mast cells secrete 5-HT (162, 165) , which can also cause epithelial secretion.
T cell activation inhibits intestinal Na + absorption, increases Cl − secretion, increases intestinal permeability, and causes diarrhea. Tumor necrosis factor-α (TNF-α) and interferon-γ (IFN-γ) mediate these T cell-elicited physiological changes. In mouse jejunum, TNF-α inhibits epithelial NHE3 (apically) and NKA (basolaterally) (166, 167) , thereby decreasing transepithelial NaCl absorption. IFN-γ reduces the transcriptional activity of the nhe3 gene in rat ileum and colon and in Caco-2/bbe cells (168) , decreasing the number of NHE3 transporters and thus decreasing NaCl absorption. Finally, IFN-γ also reduces Slc26a3 and Slc26a6 expression in Caco-2 cells (169, 170) , likely decreasing Cl − uptake. Again, the net result is decreased intestinal NaCl absorption.
SUMMARY POINTS
1. Electroneutral NaCl absorption by the small intestine is mediated by NHE2, NHE3, Slc26a3, Slc26a6, and Slc26a9 at the apical membrane and by NKA at the basolateral membrane of the small intestine. Physiological analyses of knockout mice demonstrate that facilitating electroneutral NaCl absorption is the dominant function of NHE3, Slc26a3, and Slc26a6 in the intestine.
Intracellular pH and intracellular [HCO 3
− ] control intestinal NaCl absorption directly (with H + and HCO 3 − as substrates) and indirectly (through pH dependency of transporters and metabolic HCO 3 − production).
3. Direct interaction or NHERF-mediated interaction among NHE3, Slc26s, CFTR, and protein kinases regulates transport activities. Electroneutral NaCl absorption and electrogenic Cl − secretion are oppositely controlled by intracellular cAMP, Ca 2+ , and cGMP.
4. The endocrine system, autonomic nerve system, and immune system can regulate epithelial NaCl transport function directly or indirectly via the enteric nervous system and transporter gene expression.
FUTURE ISSUES
1. Does control of the basolateral transporters and channels in the intestine involve merely a few key proteins, or is such control more complicated?
2. How does diet affect intestinal NaCl absorption? For example, can abundance of apical transport substrates (e.g., sulfate, oxalate) control efficacy of NaCl absorption?
3. What is the clinical effect of intestinal resection on NaCl absorption?
4. Does systemic acid-base status affect intestinal NaCl absorption?
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